Therapeutic interventions such as resveratrol and metformin effectively attenuate cardiac hypertrophy by activating AMPK and inhibiting the mTOR pathway (Dolinsky et al., 2009; Fu et al., 2011). This evidence concerns the gene MTOR and cardiac hypertrophy.